Hypothesis-driven weight of evidence framework for evaluating data within the US EPA's Endocrine Disruptor Screening...

Area of Science:

• Endocrinology
• Toxicology
• Risk Assessment

Background:

• Weight of Evidence (WoE) approaches are crucial for integrating diverse study results to draw conclusions.
• Assessing hormonally active agents requires evaluating screening assays, toxicity tests, mode of action studies, and pharmacokinetic data.

Purpose of the Study:

• To describe a hypothesis-driven WoE approach for evaluating hormonally active agents.
• To illustrate this approach for assessing interactions with estrogen, androgen, thyroid pathways, and related enzyme systems within the US EPA's Endocrine Disruptor Screening Program.

Main Methods:

• Constructing specific hypotheses to test for agonist/antagonist activity.
• Evaluating data validity using published recommendations.
• Proposing quantitative relevance and response weightings based on data parameters.

Main Results:

• Relevance weightings reflect how well each endpoint probes a specific hypothesis.
• Response weightings compare test substance assay results to controls and prototype hormones.
• Overall WoE scores and narratives are derived from these weightings.

Conclusions:

• The described WoE approach provides a structured framework for evaluating endocrine disruptor data.
• This method aids in characterizing potential risks of hormonally active agents.
• It supports informed decision-making within regulatory programs like the US EPA's EDSP.